Management of bleeding GI tumors.
Heller
Stephen J
SJ
Department of Medicine, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
Tokar
Jeffrey L
JL
Nguyen
Minhhuyen T
MT
Haluszka
Oleh
O
Weinberg
David S
DS
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D015179:Colorectal Neoplasms / Q000150:complications; D015897:Comorbidity; D004564:Electrocoagulation / Q000379:methods; D006471:Gastrointestinal Hemorrhage / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy*; D005770:Gastrointestinal Neoplasms / Q000150:complications* / Q000453:epidemiology; D016558:Hemostasis, Endoscopic; D006801:Humans; D008028:Light Coagulation; D009503:Neutropenia / Q000453:epidemiology; D012004:Rectal Neoplasms / Q000150:complications; D013274:Stomach Neoplasms / Q000150:complications; D013921:Thrombocytopenia / Q000150:complications
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab